<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35307855</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2075</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>Hyperphosphorylation tunes TDP-43 solubility.</ArticleTitle><Pagination><StartPage>e111062</StartPage><MedlinePgn>e111062</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e111062</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embj.2022111062</ELocationID><Abstract><AbstractText>Post-translational modifications of intrinsically disordered regions (IDRs) enable changes in sequence chemistry, which in turn can tune conformational behavior and molecular interactions. In this issue of The EMBO Journal, Gruijs da Silva et al disentangle the effect of hyperphosphorylation on the C-terminal domain of TDP-43, a key IDR implicated in Amyotrophic Lateral Sclerosis (ALS).</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ginell</LastName><ForeName>Garrett M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0001-6511-5480</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Science &amp; Engineering of Living Systems (CSELS), Washington University in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holehouse</LastName><ForeName>Alex S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-4155-5729</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Science &amp; Engineering of Living Systems (CSELS), Washington University in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>21</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35307855</ArticleId><ArticleId IdType="pmc">PMC9016343</ArticleId><ArticleId IdType="doi">10.15252/embj.2022111062</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL (2016) ALS mutations disrupt phase separation mediated by &#x3b1;&#x2010;helical structure in the TDP&#x2010;43 low&#x2010;complexity C&#x2010;terminal domain. Structure 24: 1537&#x2013;1549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruijs da Silva LA, Simonetti F, Hutten S, Riemenschneider H, Sternburg EL, Pietrek LM, Gebel J, D&#xf6;tsch V, Edbauer D, Hummer G et&#xa0;al (2022) Disease&#x2010;linked TDP&#x2010;43 hyperphosphorylation suppresses TDP&#x2010;43 condensation and aggregation. EMBO J 41: e108443</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H&#x2010;R, Chiang W&#x2010;C, Chou P&#x2010;C, Wang W&#x2010;J, Huang J&#x2010;R (2018) TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) liquid&#x2013;liquid phase separation is mediated by just a few aromatic residues. J Biol Chem 293: 6090&#x2013;6098</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5912450</ArticleId><ArticleId IdType="pubmed">29511089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis&#x2010;Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ et al (2019) RNA binding antagonizes neurotoxic phase transitions of TDP&#x2010;43. Neuron 102: 321&#x2013;338.e8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163: 123&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, O&#x2019;Meally R, Dignon GL, Conicella AE, Zheng W et al (2017) Phosphorylation of the FUS low&#x2010;complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J 36: 2951&#x2013;2967</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HB, Barreau A, Rohatgi R (2019) Phase separation&#x2010;deficient TDP43 remains functional in splicing. Nat Commun 10: 4890</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6814767</ArticleId><ArticleId IdType="pubmed">31653829</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen H&#x2010;J, Shaw CE (2015) TDP&#x2010;43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12: 352&#x2013;363</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E et al (2008) TDP&#x2010;43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Choi J&#x2010;M, Holehouse AS, Lee HO, Zhang X, Jahnel M, Maharana S, Lemaitre R, Pozniakovsky A, Drechsel D et al (2018) A molecular grammar governing the driving forces for phase separation of prion&#x2010;like RNA binding proteins. Cell 174: 688&#x2013;699.e16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>